The hazard ratio (HR) for the primary endpoint was (3.84, p = 0.0009) in the first month The Prolocor pFCG™ test has the potential to help providers reduce 30-day readmission rates for Acute MI, an ...

Xperi Inc. (NYSE: XPER) (the "Company" or "Xperi"), an entertainment technology company that invents, develops, and delivers technologies that enable extraordinary experiences, today announced third ...

The Company reported revenue of $195.2 million, an increase of $4.0 million from the third quarter of 2024. The higher revenue in the third quarter of 2025 was due primarily to higher capital project ...